Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing

Stroke is the second cause of death worldwide with ischemic stroke accounting for 80% of all stroke insults. Caspase-3 activation contributes to brain tissue loss and downstream biochemical events that lead to programmed cell death after traumatic brain injury. Alleviation of symptoms following ischemic neuronal injury can be potentially achieved by either genetic disruption or pharmacological inhibition of caspases. Here, we studied whether silencing of Caspase-3 using carbon nanotube-mediated in vivo RNA interference (RNAi) could offer a therapeutic opportunity against stroke. Effective delivery of siRNA directly to the CNS has been shown to normalize phenotypes in animal models of several neurological diseases. It is shown here that peri-lesional stereotactic administration of a Caspase-3 siRNA (siCas 3) delivered by functionalized carbon nanotubes (f-CNT) reduced neurodegeneration and promoted functional preservation before and after focal ischemic damage of the rodent motor cortex using an endothelin-1 induced stroke model. These observations illustrate the opportunity offered by carbon nanotube-mediated siRNA delivery and gene silencing of neuronal tissue applicable to a variety of different neuropathological conditions where intervention at well localized brain foci may offer therapeutic and functional benefits.

[1]  N. Lee,et al.  Amine-modified single-walled carbon nanotubes protect neurons from injury in a rat stroke model. , 2011, Nature nanotechnology.

[2]  Maurizio Prato,et al.  Enhanced cellular internalization and gene silencing with a series of cationic dendron‐multiwalled carbon nanotube:siRNA complexes , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  R. Whitby,et al.  Stimulation of neuronal neurite outgrowth using functionalized carbon nanotubes , 2010, Nanotechnology.

[4]  B. Badie,et al.  Carbon nanotube uptake and toxicity in the brain. , 2010, Methods in molecular biology.

[5]  Patrick Couvreur,et al.  A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.

[6]  K Kostarelos,et al.  Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. , 2009, Nature nanotechnology.

[7]  Maurizio Prato,et al.  Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. , 2009, Journal of the American Chemical Society.

[8]  M. Prato,et al.  Cancer therapy: Small 10/2009 , 2009 .

[9]  M. Prato,et al.  Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. , 2009, Small.

[10]  John H. Zhang,et al.  Early inhibition of HIF-1α with small interfering RNA reduces ischemic–reperfused brain injury in rats , 2009, Neurobiology of Disease.

[11]  T. Pizzorusso,et al.  Pluronic-coated carbon nanotubes do not induce degeneration of cortical neurons in vivo and in vitro. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[12]  Maria R. Gumina,et al.  Interaction between carbon nanotubes and mammalian cells: characterization by flow cytometry and application , 2008, Nanotechnology.

[13]  B. Badie,et al.  Internalization of MWCNTs by microglia: Possible application in immunotherapy of brain tumors , 2007, NeuroImage.

[14]  Maurizio Prato,et al.  CELL-PENETRATING CNTS FOR DELIVERY OF THERAPEUTICS , 2007 .

[15]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[16]  M. Prato,et al.  Intracellular Trafficking of Carbon Nanotubes by Confocal Laser Scanning Microscopy , 2007 .

[17]  D. Heistad,et al.  Gene therapy for stroke: 2006 overview , 2007, Current hypertension reports.

[18]  W. Pardridge.  shRNA and siRNA delivery to the brain. , 2007, Advanced drug delivery reviews.

[19]  M. Prato,et al.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. , 2007, Nature nanotechnology.

[20]  Yuan Zhang,et al.  Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth , 2006, Clinical Cancer Research.

[21]  Priti Kumar,et al.  A Single siRNA Suppresses Fatal Encephalitis Induced by Two Different Flaviviruses , 2006, PLoS medicine.

[22]  Zhixin Guo,et al.  Carbon Nanotube Delivery of the GFP Gene into Mammalian Cells , 2006, Chembiochem : a European journal of chemical biology.

[23]  I. Kanazawa,et al.  Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA , 2005, Neuroscience Research.

[24]  Zhuang Liu,et al.  Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. , 2005, Journal of the American Chemical Society.

[25]  F. Natt,et al.  siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain , 2005, Molecular Psychiatry.

[26]  K. Leong,et al.  Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. , 2005, Angewandte Chemie.

[27]  M. Prato,et al.  Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. , 2005, Journal of the American Chemical Society.

[28]  M. Prato,et al.  Translocation of bioactive peptides across cell membranes by carbon nanotubes. , 2004, Chemical communications.

[29]  M. Prato,et al.  Functionalized carbon nanotubes for plasmid DNA gene delivery. , 2004, Angewandte Chemie.

[30]  S. Iversen,et al.  The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke , 2004, Behavioural Brain Research.

[31]  F. Natt,et al.  siRNA relieves chronic neuropathic pain. , 2004, Nucleic acids research.

[32]  M. Prato,et al.  Amino acid functionalisation of water soluble carbon nanotubes. , 2002, Chemical communications.

[33]  Yang Shi,et al.  RNA Interference Reveals a Requirement for Myocyte Enhancer Factor 2A in Activity-dependent Neuronal Survival* , 2002, The Journal of Biological Chemistry.

[34]  M. Prato,et al.  Purification of HiPCO carbon nanotubes via organic functionalization. , 2002, Journal of the American Chemical Society.

[35]  L. Greene,et al.  The Basic Region and Leucine Zipper Transcription Factor MafK Is a New Nerve Growth Factor-Responsive Immediate Early Gene That Regulates Neurite Outgrowth , 2002, The Journal of Neuroscience.

[36]  K. Kosik,et al.  RNAi functions in cultured mammalian neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Raston,et al.  Ni(II) N4-macrocycle grafted crown ether: caesium cobalt(III) bis(dicarbollide) coordination polymer. , 2002, Chemical communications.

[38]  E. Clementi,et al.  Inhibition of Caspase-1-Like Activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl Ketone Induces Long-Lasting Neuroprotection in Cerebral Ischemia through Apoptosis Reduction and Decrease of Proinflammatory Cytokines , 2000, The Journal of Neuroscience.

[39]  Simon C Watkins,et al.  Caspase‐3 Mediated Neuronal Death After Traumatic Brain Injury in Rats , 2000, Journal of neurochemistry.

[40]  E. Slee,et al.  Serial killers: ordering caspase activation events in apoptosis , 1999, Cell Death and Differentiation.

[41]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[42]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[43]  Guo-Yuan Yang,et al.  Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.